All Stories

  1. Randomized crossover study in patients with neuroendocrine tumors to assess patient preference for lanreotide Autogel® given by either self/partner or a health care professional

    Article • Patient Preference and Adherence, October 2012, Dove Medical Press

    Associate Professor Dan Granberg, PhD Jan Calissendorff, Clinical Chair Professor Henning Gronbaek